12-year-old Kendric Cromer, a US sickle cell patient, receives first approved gene therapy at Children's National Hospital.
12-year-old Kendric Cromer, suffering from debilitating pain due to sickle cell disease, is the first patient in the US to receive a newly approved gene therapy at Children's National Hospital in D.C. His mother, Deb Cromer, remains hopeful about the treatment, which could transform care for thousands of people. By next year, Kendric could become the first person cured of sickle cell with gene therapy.
May 22, 2024
7 Articles